Personalized neuroscience is a burgeoning field that integrates neuroscience with personalized medicine. It aims to understand individual differences in brain structure, function, and connectivity to tailor interventions and treatments for various neurological and psychiatric conditions. Traditional approaches in neuroscience often treat all individuals as similar, overlooking the inherent diversity in brain function and response to treatments. However, with advances in technology such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and genetics, researchers can now delve deeper into the unique characteristics of each person's brain. One of the key aspects of personalized neuroscience is the utilization of biomarkers to characterize brain health and predict responses to interventions. These biomarkers can include genetic markers, neural activity patterns, and neuroimaging signatures. By identifying these biomarkers, clinicians can develop personalized treatment plans that are tailored to an individual's specific neurobiological profile. Furthermore, personalized neuroscience holds promise in various domains, including mental health, neurodegenerative diseases, and cognitive enhancement. For example, in psychiatry, clinicians can use personalized neuroscience approaches to optimize medication selection and dosages based on a patient's neurobiological makeup, potentially minimizing side effects and improving treatment outcomes. In neurodegenerative diseases such as Alzheimer's and Parkinson's, personalized neuroscience may enable early detection and intervention, ultimately delaying disease progression. Overall, personalized neuroscience represents a paradigm shift in how we understand and treat neurological and psychiatric conditions. By recognizing and embracing individual variability in brain structure and function, researchers and clinicians can develop more effective and targeted interventions, ultimately improving patient outcomes and quality of life.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States